Search results for " sandoz"
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
Leading generic-drug firms, including Sandoz, Mylan, and Teva, are active in this area as well. As a result, analysts expect that several additional mAbs will be approved in both developed and emergin…
Article
EMA Collaborates with HTA Assessment Networks
“Prior to a pro-biosimilar initiative in Hungary the country had the lowest uptake of biosimilars in Central and Eastern Europe,” Ken Walsh, responsible for global pricing and market access at Sandoz …
Article
Regulation of Biosimilars: A Matter of Variability, Similarity, and Comparability
Joerg Windisch, EBG chair and chief science officer of Sandoz Pharmaceuticals, stressed that comparability between biosimilars and their reference products included having similar variabilities, parti…